Solid Archives

Solid Updates Strategy to Develop SGT-001 & SGT-003 for Duchenne

April 27, 2022

Today, Solid Biosciences announced a change to its corporate strategy to better align resources with goals to bring SGT-001 and SGT-003 to patients. Key Takeaways: Enrollment in IGNITE DMD, its […]

IGNITE DMD Phase I/II Clinical Trial Update

March 15, 2022

Solid Biosciences issued a press release providing new, positive 2-year data from their IGNITE DMD clinical study in advance of the 2022 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference. […]